Skip to content
Back to announcement

20231103_MEDC_Laporan Informasi dan Fakta Material_31485014_lamp1.pdf

Other Text extracted MEDC

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
PT Medco Energi Internasional Tbk               Tel +62-21 2995 3000
The Energy 53rd Fl., SCBD Area Lot 11 A         Fax +62-21 2995 3001
Jl. Jend. Sudirman, Jakarta 12190              www.medcoenergi.com
Indonesia




                                  MedcoEnergi Announces Nine Months 2023 Results

                                                   Summary Result
 Financial
     EBITDA US$941 million
     Net Income US$242 million
     Net Debt to EBITDA1 1.6x
     Cash and cash equivalents US$666 million

Operational
   Oil & Gas production 161 mboepd
   Power generated sales 3,079 GWh
   Oil & Gas cash production cost US$7.5 per boe
   Capital expenditures US$210 million




Jakarta, November 1, 2023 – PT Medco Energi Internasional Tbk announces its 2023 nine months financial
results.

Roberto Lorato, Chief Executive Officer, stated, "I am pleased to report another quarter of solid operational
and good financial results. The recent reserve reports showing increased Natuna and Corridor reserves are
the result of MedcoEnergi’s capabilities and continued investment in our high quality assets. In order to add
value we will continue to focus on cost leadership and first class project delivery."

Financial Highlights
 The Company will pay an interim dividend for 2023 of IDR15/share.
 Net Profit for the first nine months was US$242 million, and EBITDA US$941 million reflecting lower oil
    and gas prices and reduced contribution from AMMN.
 Oil & gas production however was flat year-on-year at 161 mboepd. Prices averaged US$77/bbl for
    the first nine months of 2023, down by US$24.1/bbl from the US$101.1/bbl in the same period in
    2022. Prices in Q3 2023 recovered to US$80/bbl.
 MedcoEnergi share of AMMN net profit was US$13 million, down by US$159 million year-on-year.
 New reserve reports on Natuna and Corridor extended MedcoEnergi proved and probable reserve life
    to 9.7 years.
 Capital expenditures were US$210 million, spent mainly progressing Natuna, Corridor and Ijen
    developments.
 Consolidated debt was US$2.9 billion down by 12% year-on-year, Restricted Group debt was US$2.5
    billion or down by 14% year-on-year.
 Cash and cash equivalents were US$666 million with Net Debt US$2.2 billion and Net Debt to EBITDA1
    at 1.6x.
 In Q4 2023 a tender offer bought back US$425mn of USD Notes 2025 – 2028 and a new US$500mn
    2029 USD Note was issued for refinance.




1 Annualized and excluding PT Medco Power Indonesia (“MPI” or “Medco Power”)
Page 2
PT Medco Energi Internasional Tbk                             Tel +62-21 2995 3000
The Energy 53rd Fl., SCBD Area Lot 11 A                       Fax +62-21 2995 3001
Jl. Jend. Sudirman, Jakarta 12190                            www.medcoenergi.com
Indonesia




Operational Highlights
Oil & Gas
 Oil & gas production was 161 mboepd flat year-on-year, cash costs US$7.5 per boe.
 Oil & gas capital expenditure was US$155 million, mainly to progress several development projects in
    Natuna and Corridor.
 Corridor domestic GSA renewal is in progress and expected to be signed before year end.

Power
 Medco Power generated sales of 3,079 GWh, with 20% from renewable sources. Sales improved 5%,
   year-on-year from the contribution of Riau 275MW gas-fired IPP and Sumbawa 26 MWp solar PV
   facilities.
 Average realized electricity price were US¢ 3.7/kwh net of fuel costs, up by 2.8% year-on-year.
 Power capital expenditure was US$55 million, mainly to progress the development of Ijen Geothermal
   34MW which is on track for completion by December 2024.
 Signed a new partnership with MOECO to evaluate the Bonjol Geothermal asset.

Amman Mineral Internasional
 AMMN incurred higher compliance costs due to the delayed issue of the export permit, an export duty
  increase and began accruing the Non-Tax Government Revenue.
 Copper production was 199Mlbs, and gold production 259Koz.
 Average realized copper prices were US$4.0/lbs.
 Smelter construction is on schedule to achieve >70% by year-end.


                                                             2023 Full Year Guidance

  2023 Full Year Guidance:
     Oil & gas production 160 mboepd
     Power sales 4,000 GWh
     Oil & gas unit cash costs below US$10/boe
     Capital expenditures Oil & Gas US$250 million and Power US$80 million


President Director Hilmi Panigoro stated, "I am very pleased with our operational and financial performance.
The recent bond issuance and strong bond investors support confirms the Company’s record of consistent
delivery on our commitments and deleveraging plans. With the improving commodity prices and energy
demand we look forward to continuing on our path of sustainable growth.”
PT Medco Energi Internasional Tbk (“MedcoEnergi”) is a leading Southeast Asian energy and natural resources company listed on the Indonesia Stock Exchange
(MEDC-IDX). MedcoEnergi has three key business segments, Oil & Gas, Power and Copper Mining. MedcoEnergi explores for and produces oil and gas primarily
in Indonesia. The Group operates gas, PV, geothermal and hydro power plants in Indonesia through Medco Power and has a non-consolidated interest in PT
Amman Mineral Internasional Tbk which operates a large copper and gold mine.

This document may contain projections, plans, strategies, policies and objectives of MedcoEnergi which should be treated as forward looking statements within
the meaning of applicable law. Forward looking statements, by their nature, involve risks and uncertainties that could cause actual results to differ materially
from those expressed or implied in these statements. The Company does not guarantee that any action taken in reliance on this document will bring specific
results.

                                                        For further information please call:
                            Corporate Secretary | Investor Relations | Tel: (62-21) 2995 3000, Fax: (62-21) 2995 3001
                             Email: corporate.secretary@medcoenergi.com | investor.relations@medcoenergi.com
                                                        Website: www.medcoenergi.com

File

File Open PDF
Source IDX
Size0.16 MB
Published3 Nov 2023
Pages2
Characters6,151
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 0 people and organisations named in the text · linked when the evidence is strong

The name pass has not read this document yet.

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result